1.
Piekarz R, Frye R, Turner M, Turner J, Allen S, Kirschbaum M, Zain J, Prince M. Phase II trial of romidepsin (FK228 or depsipeptide) in peripheral T-cell lymphoma: clinical activity and molecular markers. Hematol Meeting Rep [Internet]. 2009 Jun. 10 [cited 2024 Dec. 22];2(13). Available from: https://www.pagepress.org/journals/hmr/article/view/482